Ignite Creation Date:
2025-12-24 @ 4:42 PM
Ignite Modification Date:
2026-01-02 @ 10:39 AM
Study NCT ID:
NCT01788566
Status:
COMPLETED
Last Update Posted:
2016-06-27
First Post:
2013-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-07
First Submit QC Date:
None
Study First Post Date:
2013-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-21
Results First Submit QC Date:
None
Results First Post Date:
2016-06-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-10-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-05-20
Last Update Post Date:
2016-06-27
Last Update Post Date Type:
ESTIMATED